Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia

• Status: Completed
• Trial end date: 2008-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind extension study for patients who participated in study NK-104-305.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kowa Research Europe
• Treatments: Atorvastatin; Atorvastatin Calcium; Pitavastatin

Criteria

Inclusion Criteria:

• Type II diabetes mellitus

• Combined dyslipidemia

• Completed NK-104-305 (NCT00309751)

Exclusion Criteria:

• Withdrawal from NK-104-305 (NCT00309751)